RedHill Biopharma (RDHL) Asset Utilization Ratio (2013 - 2023)

RedHill Biopharma (RDHL) has 10 years of Asset Utilization Ratio data on file, last reported at 0.76 in Q2 2023.

• Asset Utilization Ratio for Q2 2023 came in at 0.76, up 69.8% year-over-year; the trailing twelve-month figure through Jun 2023 was 0.76 (up 69.8% YoY), and the FY2025 annual result was 0.01, down 96.63% from the prior year.
• Asset Utilization Ratio rose to 0.76 in Q2 2023 per RDHL's latest filing, from 0.48 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.76 in Q2 2023 and troughed at 0.05 in Q1 2020.
• A 5-year average of 0.34 and a median of 0.39 in 2021 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2020 and 2021: Asset Utilization Ratio slumped 59.38% in 2020, then surged 712.54% in 2021.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.11 in 2019, then jumped by 234.97% to 0.37 in 2020, then grew by 26.61% to 0.47 in 2021, then decreased by 16.2% to 0.39 in 2022, then jumped by 94.75% to 0.76 in 2023.
• Business Quant data shows RDHL's Asset Utilization Ratio at 0.76 in Q2 2023, 0.48 in Q1 2023, and 0.39 in Q4 2022.